Enzo Biochem said after the close of markets on Thursday that it has entered an agreement to sell the assets of its clinical laboratory division to Laboratory Corporation of America.

Abbott announced on Tuesday that its laboratory-based test for traumatic brain injuries has received clearance from the US Food and Drug Administration.

On June 16, 2021, AVE Science & Technology Co. Ltd. was listed on the Sci-Tech innovation board. The number of A shares publicly issued this time is 17 million shares, the issue price is 14.71 yuan/share, the opening price is 38.24 yuan/share, and the maximum increase at the time of press is 207%.